Apolipoprotein H variant modifies plasma triglyceride phenotype in familial hypercholesterolemia: a molecular study in an eight-generation hyperlipidemic family.

Daisuke Takada, Yoichi Ezura, Shuji Ono, Yasuhiko Iino, Yasuo Katayama, Yuanpei Xin, Lily L. Wu, Stacey Larringa-Shum, Susan H. Stephenson, Steven Hunt, Paul N. Hopkins, Mitsuru Emi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

In the course of investigating familial coronary artery disease in Utah, we studied 196 members of an eight-generation extended family of familial hypercholesterolemia (FH), in which 73 members were affected with type IIa hyperlipoproteinemia (HLPIIa; high plasma cholesterol) and 11 members with type IIb hyperlipoproteinemia (HLPIIb; high plasma cholesterol as well as plasma triglyceride). A splice-site mutation of the LDL receptor (LDLR) gene (IVS14 + G > A) co-segregated with elevated plasma cholesterol among all the members, but not with the elevated plasma triglyceride and VLDL cholesterol levels seen in HLPIIb patients. The apolipoprotein H (apoH) gene plays a role in plasma triglyceride removal and lipoprotein lipase enhancement. Intra-familial correlation analysis of the modifier effect of Val247Leu substitution in the apoH gene was carried out among 84 LDLR-mutation carriers and 112 non-carriers. When plasma triglyceride levels in the LDLR-mutation carriers were compared, the values were lowest among V/V homozygotes (mean +/- SD = 145 +/- 53 mg/dl), highest in L/L homozygotes (277 +/- 177 mg/dl), and intermediate among V/L heterozygotes (191 +/- 102 mg/dl) (p = 0.0015). All eleven patients who presented with HLPIIb had inherited both the defective LDLR allele and an apoH 247Leu allele, whereas all 45 carriers of the defective LDLR allele not carrying the apoH Leu allele presented with HLPIIa but not HLPIIb (p = 0.0001). These results indicate a significant modification of the phenotype of FH with a defective LDLR allele, by apoH Leu variation in our studied family.

Original languageEnglish
Pages (from-to)79-84
Number of pages6
JournalJournal of Atherosclerosis and Thrombosis
Volume10
Issue number2
Publication statusPublished - 2003
Externally publishedYes

Fingerprint

beta 2-Glycoprotein I
Hyperlipoproteinemia Type II
LDL Receptors
Triglycerides
Phenotype
Plasmas
Alleles
Genes
Cholesterol
Homozygote
Mutation
VLDL Cholesterol
Lipoprotein Lipase
Heterozygote
Hypercholesterolemia
Lipase
Coronary Artery Disease
Substitution reactions

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine
  • Biochemistry, medical

Cite this

Apolipoprotein H variant modifies plasma triglyceride phenotype in familial hypercholesterolemia : a molecular study in an eight-generation hyperlipidemic family. / Takada, Daisuke; Ezura, Yoichi; Ono, Shuji; Iino, Yasuhiko; Katayama, Yasuo; Xin, Yuanpei; Wu, Lily L.; Larringa-Shum, Stacey; Stephenson, Susan H.; Hunt, Steven; Hopkins, Paul N.; Emi, Mitsuru.

In: Journal of Atherosclerosis and Thrombosis, Vol. 10, No. 2, 2003, p. 79-84.

Research output: Contribution to journalArticle

Takada, D, Ezura, Y, Ono, S, Iino, Y, Katayama, Y, Xin, Y, Wu, LL, Larringa-Shum, S, Stephenson, SH, Hunt, S, Hopkins, PN & Emi, M 2003, 'Apolipoprotein H variant modifies plasma triglyceride phenotype in familial hypercholesterolemia: a molecular study in an eight-generation hyperlipidemic family.', Journal of Atherosclerosis and Thrombosis, vol. 10, no. 2, pp. 79-84.
Takada, Daisuke ; Ezura, Yoichi ; Ono, Shuji ; Iino, Yasuhiko ; Katayama, Yasuo ; Xin, Yuanpei ; Wu, Lily L. ; Larringa-Shum, Stacey ; Stephenson, Susan H. ; Hunt, Steven ; Hopkins, Paul N. ; Emi, Mitsuru. / Apolipoprotein H variant modifies plasma triglyceride phenotype in familial hypercholesterolemia : a molecular study in an eight-generation hyperlipidemic family. In: Journal of Atherosclerosis and Thrombosis. 2003 ; Vol. 10, No. 2. pp. 79-84.
@article{ca1cd88d01c74854b4356509eedcbb39,
title = "Apolipoprotein H variant modifies plasma triglyceride phenotype in familial hypercholesterolemia: a molecular study in an eight-generation hyperlipidemic family.",
abstract = "In the course of investigating familial coronary artery disease in Utah, we studied 196 members of an eight-generation extended family of familial hypercholesterolemia (FH), in which 73 members were affected with type IIa hyperlipoproteinemia (HLPIIa; high plasma cholesterol) and 11 members with type IIb hyperlipoproteinemia (HLPIIb; high plasma cholesterol as well as plasma triglyceride). A splice-site mutation of the LDL receptor (LDLR) gene (IVS14 + G > A) co-segregated with elevated plasma cholesterol among all the members, but not with the elevated plasma triglyceride and VLDL cholesterol levels seen in HLPIIb patients. The apolipoprotein H (apoH) gene plays a role in plasma triglyceride removal and lipoprotein lipase enhancement. Intra-familial correlation analysis of the modifier effect of Val247Leu substitution in the apoH gene was carried out among 84 LDLR-mutation carriers and 112 non-carriers. When plasma triglyceride levels in the LDLR-mutation carriers were compared, the values were lowest among V/V homozygotes (mean +/- SD = 145 +/- 53 mg/dl), highest in L/L homozygotes (277 +/- 177 mg/dl), and intermediate among V/L heterozygotes (191 +/- 102 mg/dl) (p = 0.0015). All eleven patients who presented with HLPIIb had inherited both the defective LDLR allele and an apoH 247Leu allele, whereas all 45 carriers of the defective LDLR allele not carrying the apoH Leu allele presented with HLPIIa but not HLPIIb (p = 0.0001). These results indicate a significant modification of the phenotype of FH with a defective LDLR allele, by apoH Leu variation in our studied family.",
author = "Daisuke Takada and Yoichi Ezura and Shuji Ono and Yasuhiko Iino and Yasuo Katayama and Yuanpei Xin and Wu, {Lily L.} and Stacey Larringa-Shum and Stephenson, {Susan H.} and Steven Hunt and Hopkins, {Paul N.} and Mitsuru Emi",
year = "2003",
language = "English",
volume = "10",
pages = "79--84",
journal = "Journal of Atherosclerosis and Thrombosis",
issn = "1340-3478",
publisher = "Japan Atherosclerosis Society",
number = "2",

}

TY - JOUR

T1 - Apolipoprotein H variant modifies plasma triglyceride phenotype in familial hypercholesterolemia

T2 - a molecular study in an eight-generation hyperlipidemic family.

AU - Takada, Daisuke

AU - Ezura, Yoichi

AU - Ono, Shuji

AU - Iino, Yasuhiko

AU - Katayama, Yasuo

AU - Xin, Yuanpei

AU - Wu, Lily L.

AU - Larringa-Shum, Stacey

AU - Stephenson, Susan H.

AU - Hunt, Steven

AU - Hopkins, Paul N.

AU - Emi, Mitsuru

PY - 2003

Y1 - 2003

N2 - In the course of investigating familial coronary artery disease in Utah, we studied 196 members of an eight-generation extended family of familial hypercholesterolemia (FH), in which 73 members were affected with type IIa hyperlipoproteinemia (HLPIIa; high plasma cholesterol) and 11 members with type IIb hyperlipoproteinemia (HLPIIb; high plasma cholesterol as well as plasma triglyceride). A splice-site mutation of the LDL receptor (LDLR) gene (IVS14 + G > A) co-segregated with elevated plasma cholesterol among all the members, but not with the elevated plasma triglyceride and VLDL cholesterol levels seen in HLPIIb patients. The apolipoprotein H (apoH) gene plays a role in plasma triglyceride removal and lipoprotein lipase enhancement. Intra-familial correlation analysis of the modifier effect of Val247Leu substitution in the apoH gene was carried out among 84 LDLR-mutation carriers and 112 non-carriers. When plasma triglyceride levels in the LDLR-mutation carriers were compared, the values were lowest among V/V homozygotes (mean +/- SD = 145 +/- 53 mg/dl), highest in L/L homozygotes (277 +/- 177 mg/dl), and intermediate among V/L heterozygotes (191 +/- 102 mg/dl) (p = 0.0015). All eleven patients who presented with HLPIIb had inherited both the defective LDLR allele and an apoH 247Leu allele, whereas all 45 carriers of the defective LDLR allele not carrying the apoH Leu allele presented with HLPIIa but not HLPIIb (p = 0.0001). These results indicate a significant modification of the phenotype of FH with a defective LDLR allele, by apoH Leu variation in our studied family.

AB - In the course of investigating familial coronary artery disease in Utah, we studied 196 members of an eight-generation extended family of familial hypercholesterolemia (FH), in which 73 members were affected with type IIa hyperlipoproteinemia (HLPIIa; high plasma cholesterol) and 11 members with type IIb hyperlipoproteinemia (HLPIIb; high plasma cholesterol as well as plasma triglyceride). A splice-site mutation of the LDL receptor (LDLR) gene (IVS14 + G > A) co-segregated with elevated plasma cholesterol among all the members, but not with the elevated plasma triglyceride and VLDL cholesterol levels seen in HLPIIb patients. The apolipoprotein H (apoH) gene plays a role in plasma triglyceride removal and lipoprotein lipase enhancement. Intra-familial correlation analysis of the modifier effect of Val247Leu substitution in the apoH gene was carried out among 84 LDLR-mutation carriers and 112 non-carriers. When plasma triglyceride levels in the LDLR-mutation carriers were compared, the values were lowest among V/V homozygotes (mean +/- SD = 145 +/- 53 mg/dl), highest in L/L homozygotes (277 +/- 177 mg/dl), and intermediate among V/L heterozygotes (191 +/- 102 mg/dl) (p = 0.0015). All eleven patients who presented with HLPIIb had inherited both the defective LDLR allele and an apoH 247Leu allele, whereas all 45 carriers of the defective LDLR allele not carrying the apoH Leu allele presented with HLPIIa but not HLPIIb (p = 0.0001). These results indicate a significant modification of the phenotype of FH with a defective LDLR allele, by apoH Leu variation in our studied family.

UR - http://www.scopus.com/inward/record.url?scp=0042510741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042510741&partnerID=8YFLogxK

M3 - Article

C2 - 12740481

AN - SCOPUS:0042510741

VL - 10

SP - 79

EP - 84

JO - Journal of Atherosclerosis and Thrombosis

JF - Journal of Atherosclerosis and Thrombosis

SN - 1340-3478

IS - 2

ER -